表紙:G-CSF (顆粒球コロニー刺激因子) の世界市場の分析 (2020年~2030年):新型コロナウイルス感染症 (COVID-19) による成長と変化
市場調査レポート
商品コード
975750

G-CSF (顆粒球コロニー刺激因子) の世界市場の分析 (2020年~2030年):新型コロナウイルス感染症 (COVID-19) による成長と変化

G-CSF (Granulocyte Colony Stimutating Factors) Global Market Report 2020-30: COVID-19 Growth and Change

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
G-CSF (顆粒球コロニー刺激因子) の世界市場の分析 (2020年~2030年):新型コロナウイルス感染症 (COVID-19) による成長と変化
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のG-CSF (顆粒球コロニー刺激因子) の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し (2015~2019年、2023年、2025年、2030年)、セグメント別 (種類別・用途別) および地域別・主要国の詳細動向、主要企業のプロファイル、近年の主な傾向、今後の市場機会などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 G-CSF (顆粒球コロニー刺激因子) 市場の特徴

第3章 G-CSF市場:市場規模・成長率

  • 市場規模 (金額ベース、2015年~2019年)
  • 市場規模 (金額ベース、2019年~2023年、2025年、2030年)
    • 市場促進要因
    • 市場抑制要因

第4章 G-CSF市場:分野別の分析

  • 種類別の市場規模 (金額ベース、実績値・予測値)
    • レノグラスチム(顆粒球)
    • フィルグラスチム(Neupogen、Zarzio、Nivestim、Accofil)
    • 長時間作用型(PEG化)フィルグラスチム(pegfilgrastim、Neulasta、Pelmeg、Ziextenco)
    • Lipegfilgrastim(Lonquex)
  • 用途別の市場規模 (金額ベース、実績値・予測値)
    • 腫瘍性疾患
    • 造血系疾患
    • 成長ホルモン欠乏症
    • 慢性疾患・自己免疫疾患
    • その他

第5章 G-CSF市場:地域別・国別分析

  • 地域別の市場規模 (金額ベース、実績値・予測値)
  • 国別の市場規模 (金額ベース、実績値・予測値)

第6章 アジア太平洋のG-CSF市場

  • 市場概要
  • 種類別の市場規模 (金額ベース、実績値・予測値)
  • 用途別の市場規模 (金額ベース、実績値・予測値)

第7章 中国市場

第8章 インド市場

第9章 日本市場

第10章 オーストラリア市場

第11章 インドネシア市場

第12章 韓国市場

第13章 西欧のG-CSF市場

第14章 英国市場

第15章 ドイツ市場

第16章 フランス市場

第17章 東欧のG-CSF市場

第18章 ロシア市場

第19章 北米のG-CSF市場

第20章 米国市場

第21章 南米のG-CSF市場

第22章 ブラジル市場

第23章 中東のG-CSF市場

第24章 アフリカのG-CSF市場

第25章 G-CSF市場:競争環境と企業プロファイル

  • 競争環境
  • 企業プロファイル
    • BioCad
    • Teva Pharmaceuticals
    • Pfizer
    • Intas Pharmaceuticals
    • Novartis AG

第26章 G-CSF市場における主要な企業合併・買収 (M&A)

第27章 G-CSF市場の動向と戦略

第28章 G-CSF市場:将来展望と潜在力の分析

第29章 付録

目次

“G-CSF (Granolocyte Colony Stimutating Factors) Global Market Report 2020-30: Covid 19 Growth And Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global g-csf (granolocyte colony stimutating factors) market.

This report focuses on g-csf (granolocyte colony stimutating factors) market which is experiencing strong growth. The report gives a guide to the g-csf (granolocyte colony stimutating factors) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the g-csf (granolocyte colony stimutating factors)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward?“ The G-CSF (Granolocyte Colony Stimutating Factors) market global report ”from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider g-csf (granolocyte colony stimutating factors) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The g-csf (granolocyte colony stimutating factors) market section of the report gives context. It compares the g-csf (granolocyte colony stimutating factors) market with other segments of the g-csf (granolocyte colony stimutating factors) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, g-csf (granolocyte colony stimutating factors) indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Lenograstim (Granocyte); Filgrastim (Neupogen, Zarzio, Nivestim, Accofil); Long acting (pegylated) filgrastim (pegfilgrastim, Neulasta, Pelmeg, Ziextenco); Lipegfilgrastim (Lonquex)
  • 2) By Application: Oncological Diseases; Blood Disorders; Growth Hormone Deficiencies; Chronic and Autoimmune Disorders; Others
  • Companies Mentioned: BioCad; Teva Pharmaceuticals; Pfizer; Intas Pharmaceuticals; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. G-CSF (Granolocyte Colony Stimutating Factors) Market Characteristics

3. G-CSF (Granolocyte Colony Stimutating Factors) Market Size And Growth

  • 3.1. Global G-CSF (Granolocyte Colony Stimutating Factors) Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global G-CSF (Granolocyte Colony Stimutating Factors) Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. G-CSF (Granolocyte Colony Stimutating Factors) Market Segmentation

  • 4.1. Global G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Lenograstim (Granocyte)
  • Filgrastim (Neupogen, Zarzio, Nivestim, Accofil)
  • Long acting (pegylated) filgrastim (pegfilgrastim, Neulasta, Pelmeg, Ziextenco)
  • Lipegfilgrastim (Lonquex)
  • 4.2. Global G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oncological Diseases
  • Blood Disorders
  • Growth Hormone Deficiencies
  • Chronic and Autoimmune Disorders
  • Others

5. G-CSF (Granolocyte Colony Stimutating Factors) Market Regional And Country Analysis

  • 5.1. Global G-CSF (Granolocyte Colony Stimutating Factors) Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global G-CSF (Granolocyte Colony Stimutating Factors) Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 6.1. Asia-Pacific G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 6.2. Asia-Pacific G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 7.1. China G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 7.2. China G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 8.1. India G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 8.2. India G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 9.1. Japan G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 9.2. Japan G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 10.1. Australia G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 11.1. Indonesia G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 12.1. South Korea G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 13.1. Western Europe G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 13.2. Western Europe G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 14.1. UK G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 14.2. UK G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 15.1. Germany G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 16.4. France G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 17.1. Eastern Europe G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 17.2. Eastern Europe G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 18.1. Russia G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 19.1. North America G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 19.2. North America G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 20.1. USA G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 20.2. USA G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 21.1. South America G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 21.2. South America G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 22.1. Brazil G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 23.1. Middle East G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 23.2. Middle East G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa G-CSF (Granolocyte Colony Stimutating Factors) Market

  • 24.1. Africa G-CSF (Granolocyte Colony Stimutating Factors) Market Overview
  • 24.2. Africa G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa G-CSF (Granolocyte Colony Stimutating Factors) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. G-CSF (Granolocyte Colony Stimutating Factors) Market Competitive Landscape And Company Profiles

  • 25.1. G-CSF (Granolocyte Colony Stimutating Factors) Market Competitive Landscape
  • 25.2. G-CSF (Granolocyte Colony Stimutating Factors) Market Company Profiles
    • 25.2.1. BioCad
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Teva Pharmaceuticals
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Pfizer
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Intas Pharmaceuticals
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Novartis AG
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The G-CSF (Granolocyte Colony Stimutating Factors) Market

27. G-CSF (Granolocyte Colony Stimutating Factors) Market Trends And Strategies

28. G-CSF (Granolocyte Colony Stimutating Factors) Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer